Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004657147 | SCV005149927 | uncertain significance | Inborn genetic diseases | 2024-06-04 | criteria provided, single submitter | clinical testing | The c.47C>T (p.P16L) alteration is located in exon 1 (coding exon 1) of the PIEZO2 gene. This alteration results from a C to T substitution at nucleotide position 47, causing the proline (P) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |